CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2019ACC: 0001209191-19-006663
DirectorOfficer· President & CEO
Since Aug 2018
+21.47K
Net shares
Net buyer
$8.1K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
21.47K acquired
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
+21.47K
Price / share
$0.38
Trade value
$8.10K
% of position
7.5%
2/1/2019
285.43K→306.90K
Total
Net shares
+21.47K
Net value
$8.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 2/1/2019 | A · Award | +21.47K | $0.38 | $8.10K | 7.5% | 285.43K | 306.90K |
| Total | +21.47K | $8.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.0001 par value
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 par value | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported